5-Amino-1MQ — Complete Dosing Protocol & Guide
Research-based dosing, cycling, stacking, and side effects for weight loss protocols.
Category
🔥 Weight Loss
Route
Oral or subcutaneous
Half-life
~hours
Frequency
Once daily
Cycle length
8-12 weeks
Dose range
25 mg–50 mg / dose
What is 5-Amino-1MQ?
Small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase) — blocks nicotinamide wasting inside fat cells, preserving NAD+ and methyl donor pools, which reduces fat accumulation and supports fat loss with muscle preservation. In the research literature, 5-Amino-1MQ is classified as a weight loss peptide — it fits the fat loss, appetite control, metabolic health category.
Developed from methyl-donor metabolism research. 25-50mg daily. Popular in fat-loss stacks for its muscle-preserving profile; human clinical data is still lacking. Complementary/stack-only — supports NAD+ and fat oxidation alongside a primary protocol, never a primary pick.
In laboratory and clinical research settings, 5-Amino-1MQ is administered oral or subcutaneous at a frequency of once daily. Its elimination half-life is ~hours, which is what shapes the once daily dosing cadence. Typical research protocols dose at approximately 350 mcg/kg of body weight, giving a working range of 25 mg–50 mg per administration.
5-Amino-1MQ Dosing Protocol
Research protocols dose 5-Amino-1MQ at approximately 350 mcg/kg of body weight, which puts the per-administration range at 25 mg–50 mg. The table below shows how that scales with experience level for an 80 kg (176 lb) adult.
| Level | Dose (80 kg example) | Notes |
|---|---|---|
| Beginner | 14 mg | First cycle — start at the low end |
| Intermediate | 21 mg | 1–3 prior cycles, tolerating the range |
| Advanced | 28 mg | Multiple cycles — research protocols only |
Dose calculation formula
dose (mcg) = 350 mcg/kg × body weight (kg) × experience factor
Experience factors for 5-Amino-1MQ: beginner ×0.5, intermediate ×0.75, advanced ×1. Doses outside the 25 mg–50 mg research range are not studied.
Titration & protocol notes
Developed from methyl-donor metabolism research. 25-50mg daily. Popular in fat-loss stacks for its muscle-preserving profile; human clinical data is still lacking. Complementary/stack-only — supports NAD+ and fat oxidation alongside a primary protocol, never a primary pick.
Weight, goal, and safety screening included
Calculate your dose after mixing — prefilled for the 10mg vial
5-Amino-1MQ Cycle & Break: 8-12 weeks on, then 4 weeks off
Recommended cycle
8-12 weeks
Recommended break
4 weeks off
Why cycling matters for 5-Amino-1MQ
- Receptor sensitivity: prolonged GLP-1/incretin receptor activation leads to tachyphylaxis — the same dose produces progressively less appetite suppression and weight loss over months.
- Gastrointestinal recovery: the digestive side effects (nausea, delayed gastric emptying) accumulate with continuous exposure; planned breaks let GI function normalize.
- Assessment windows: research protocols use the break to evaluate results — how much of the benefit persisted, and whether another cycle is justified — before re-exposing.
What happens during the break
- Receptor resensitization: the biological targets regain baseline sensitivity, so the next cycle starts from full responsiveness.
- Biomarker normalization: hormone, metabolic, and inflammatory markers measured during research protocols return toward baseline.
- Consolidation: benefits built during the cycle (tissue repair, body composition, sleep quality) are consolidated through sleep, nutrition, and training rather than pharmacological stimulation.
- Reassessment: this is the window to re-run the PeptideWise protocol engine — your weight, goals, or safety profile may have changed.
Stacking 5-Amino-1MQ
Yes — 5-Amino-1MQ stacks well with AOD-9604, SLU-PP-332 in research protocols. Good stacks combine peptides that act through different mechanisms on the same goal, rather than doubling up on one pathway.
When stacking, keep cycle lengths aligned (8-12 weeks for 5-Amino-1MQ), stagger or combine doses to fit both peptides' frequencies, and introduce one new peptide at a time so individual responses stay interpretable.
Peptides that stack with 5-Amino-1MQ
AOD-9604
🔥 Weight LossFragment (177-191) of human growth hormone that retains the fat-burning (lipolytic) activity of HGH without the growth-promoting (somatotropic) or insulin-sensitizing effects
View guide →
SLU-PP-332
🔥 Weight LossFirst-in-class synthetic agonist of estrogen-related receptors (ERRα/γ) that reprograms muscle fibers toward oxidative, fatigue-resistant metabolism
View guide →
5-Amino-1MQ Side Effects & Safety
Reported side effects
- No human safety data
- Mild headache
- GI upset (oral)
Most effects are dose-dependent — reduce the dose or pause if they persist.
Contraindicated with
- Pregnant
- Breastfeeding
- Liver disease
- Kidney disease
The protocol engine removes contraindicated peptides automatically.
Research use only — read before starting
5-Amino-1MQ is sold for research purposes only and is not FDA-approved as a supplement or consumer product. Nothing on this page is medical advice. Severe reactions (chest pain, severe abdominal pain, breathing difficulty, signs of allergy) mean stop immediately and seek medical evaluation. Consult a qualified healthcare provider before starting any peptide protocol — especially with the conditions and medications listed above.
5-Amino-1MQ FAQ
What is 5-Amino-1MQ?
5-Amino-1MQ is a weight loss peptide — the weight loss category covers fat loss, appetite control, metabolic health. Small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase) — blocks nicotinamide wasting inside fat cells, preserving NAD+ and methyl donor pools, which reduces fat accumulation and supports fat loss with muscle preservation. In research settings it is administered oral or subcutaneous at a frequency of once daily, with an elimination half-life of ~hours and a studied dose range of 25 mg–50 mg per administration (about 350 mcg/kg of body weight).
How does 5-Amino-1MQ work?
Small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase) — blocks nicotinamide wasting inside fat cells, preserving NAD+ and methyl donor pools, which reduces fat accumulation and supports fat loss with muscle preservation. That mechanism places it in the weight loss category. Pharmacokinetically, its elimination half-life of ~hours is what shapes the once daily dosing cadence used in research protocols, and the full effect builds across a 8-12 weeks cycle followed by 4 weeks off — which is why the dosing is cycled rather than continuous.
How to take 5-Amino-1MQ?
5-Amino-1MQ is taken oral or subcutaneous — subcutaneous injection into abdominal fat is the standard research route. The research-standard frequency is once daily, with a half-life of ~hours. Keep administrations on the same day(s) each week so plasma levels stay steady. Always start at the low end of the dose range, use aseptic technique for injections, and follow the 8-12 weeks cycle followed by 4 weeks off. PeptideWise calculates the exact dose and schedule for your body weight and goal.
How much 5-Amino-1MQ should I take?
Research protocols use 25 mg–50 mg per administration, weight-based at roughly 350 mcg/kg of body weight, administered once daily. For an 80 kg (176 lb) adult that works out to about 14 mg for a beginner, 21 mg for an intermediate, and 28 mg for an advanced research protocol. Start at the bottom of the range and titrate up only while the response is tolerable — the personalized protocol engine on this site computes the exact figure for your weight.
How long should I cycle 5-Amino-1MQ?
The standard research cycle is 8-12 weeks, followed by 4 weeks off. Cycling matters because continuous exposure leads to receptor desensitization (tachyphylaxis) — the same dose produces less effect over time — and side effects fade during off periods. Don't extend the cycle past 8-12 weeks chasing diminishing returns.
Can I stack 5-Amino-1MQ with other peptides?
Yes. 5-Amino-1MQ is commonly researched alongside AOD-9604, SLU-PP-332. The best stacks pair peptides that act through different mechanisms toward the same goal — for example BPC-157 (angiogenesis) with TB-500 (cell migration). Introduce one peptide at a time, align cycle lengths, and cap stacks at 2–3 peptides so effects stay attributable. The protocol engine on this site only recommends stack combinations that pass safety screening for your conditions and medications.
What are the side effects of 5-Amino-1MQ?
Reported in research and trial settings: no human safety data; mild headache; gi upset (oral). Most are dose-dependent and resolve when the dose is reduced or the cycle ends. If any severe reaction occurs (chest pain, severe abdominal pain, difficulty breathing, signs of an allergic response), stop immediately and seek medical evaluation.
Is 5-Amino-1MQ safe?
5-Amino-1MQ carries a good research safety profile at the doses described above, but safety is individual. It is contraindicated in research settings with: pregnant, breastfeeding, liver disease, kidney disease. It is not medical advice to run any peptide without supervision — consult a qualified healthcare provider who knows your full history first, get baseline labs, and re-check during the cycle. 🔥 As a weight loss peptide, 5-Amino-1MQ is sold for research use only.
Where to buy 5-Amino-1MQ?
5-Amino-1MQ is sold by research-chemical suppliers for laboratory research use only — it is not an approved dietary supplement or consumer product, and regulations vary by country and jurisdiction. Before considering any source: (1) consult a licensed healthcare provider about medically supervised options, (2) if purchasing for research, verify third-party certificates of analysis (COA) confirming purity and identity, and (3) be wary of prices that look too good to be true — they usually are. PeptideWise does not sell peptides; we provide dosing research and protocol tools.
How to reconstitute 5-Amino-1MQ?
5-Amino-1MQ ships lyophilized (freeze-dried) and must be reconstituted before use. Use bacteriostatic water: inject it slowly down the inside wall of the vial (never directly onto the powder), then swirl gently — never shake, as shaking denatures the peptide. Example: a 5 mg vial + 2 mL of bacteriostatic water gives 2.5 mg/mL, so a 250 mcg dose is 10 units (0.1 mL) on an insulin syringe. Store the reconstituted vial refrigerated at 2–8°C and use within 2–4 weeks. See the full step-by-step reconstitution guide for concentration math and storage.
Continue reading
Disclaimer: This page is research and educational information only, not medical advice. 5-Amino-1MQ is sold for laboratory research use and is not approved for human consumption. Doses, cycles, and stacking information summarize published research and community protocol reports — individual risk depends on your health status, medications, and supervision. Consult a qualified healthcare provider before considering any peptide protocol. PeptideWise does not sell peptides and has no financial relationship with any supplier.
Get your personalized 5-Amino-1MQ protocol
Enter your weight, goal, and safety profile — the protocol engine calculates your exact 5-Amino-1MQdose, builds the cycle calendar, and screens every recommendation against your conditions and medications.
Build my 5-Amino-1MQ protocol